A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.
暂无分享，去创建一个
Philip R. Johnson | P. Kaleebu | L. Bekker | E. Vardas | J. Birungi | E. Chomba | P. Fast | M. Boaz | P. Hayes | J. Cox | J. Gilmour | A. Hoosen | A. Heald | J. Lehrman | C. Schmidt | G. Stevens | Mark J. Boaz | P. Anklesaria | B. Barin | Sarah Lowenbein | T. Tarragona | E. Kizito